Health Catalyst Inc’s recent filing unveils that its Chief People Officer Llewelyn Linda unloaded Company’s shares for reported $34953.0 on Feb 18 ’25. In the deal valued at $5.43 per share,6,441 shares were sold. As a result of this transaction, Llewelyn Linda now holds 85,819 shares worth roughly $0.45 million.
Then, LINDA LLEWELYN bought 6,641 shares, generating $35,994 in total proceeds.
Before that, LeSueur Daniel sold 5,209 shares. Health Catalyst Inc shares valued at $30,007 were divested by the Chief Operating Officer at a price of $5.76 per share. As a result of the transaction, LeSueur Daniel now holds 86,044 shares, worth roughly $0.45 million.
KeyBanc Capital Markets upgraded its Health Catalyst Inc [HCAT] rating to an Overweight from a a Sector weight in a research note published recently. A number of analysts have revised their coverage, including KeyBanc Capital Markets’s analysts, who decreased its forecast for the stock in early April from “an Overweight” to “a Sector weight”. Evercore ISI also remained covering HCAT and has increased its forecast on January 03, 2024 with a “an Outperform” recommendation from previously “an In-line” rating. Barclays started covering the stock on January 03, 2024. It rated HCAT as “an Overweight”.
Price Performance Review of HCAT
On Friday, Health Catalyst Inc [NASDAQ:HCAT] saw its stock fall -2.97% to $5.23. Over the last five days, the stock has lost -5.77%. Health Catalyst Inc shares have fallen nearly -26.03% since the year began. Nevertheless, the stocks have fallen -46.14% over the past one year. While a 52-week high of $9.72 was reached on 01/06/25, a 52-week low of $5.25 was recorded on 02/21/25. SMA at 50 days reached $6.42, while 200 days put it at $7.11.
Levels Of Support And Resistance For HCAT Stock
The 24-hour chart illustrates a support level at 5.12, which if violated will result in even more drops to 5.01. On the upside, there is a resistance level at 5.41. A further resistance level may holdings at 5.60. The Relative Strength Index (RSI) on the 14-day chart is 36.55, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.14, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 95.04%. Stochastics %K at 24.22% indicates the stock is a holding.
